tradingkey.logo
tradingkey.logo
Suchen

Myomo Inc

MYO
Zur Watchlist hinzufügen
1.030USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
39.72MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Myomo Inc Unternehmen

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc Informationen

BörsenkürzelMYO
Name des UnternehmensMyomo Inc
IPO-datumJun 12, 2017
CEOGudonis (Paul R)
Anzahl der mitarbeiter184
WertpapierartOrdinary Share
GeschäftsjahresendeJun 12
Addresse137 Portland Street
StadtBOSTON
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl02114
Telefon16179969058
Websitehttps://myomo.com/
BörsenkürzelMYO
IPO-datumJun 12, 2017
CEOGudonis (Paul R)

Führungskräfte von Myomo Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.36M
+7.03%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
462.35K
-4.55%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.36M
+7.03%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
462.35K
-4.55%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Myomo Inc?

Die fünf größten Anteilseigner von Myomo Inc sind: Mr. Paul R. Gudonis

Wie viele Institutionen halten Anteile an Myomo Inc (MYO)?

Mit Stand vom 2026Q1 halten 185 Institutionen Anteile an Myomo Inc, mit einem Gesamtmarktwert von etwa 23.44M, was 63.19% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -5843597.00 gestiegen.

Was ist die größte Einnahmequelle von Myomo Inc?

Am 2026Q1 erzielte das Geschäft mit Direct to patient für Myomo Inc den höchsten Umsatz in Höhe von 7.32M, was 72.56% des Gesamtumsatzes entspricht.